We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome), a rare genetic disorder increasing the risk of skin cancer and other health issues. Learn about symptoms, causes, diagnosis, and management.

Imagine a condition that affects multiple parts of your body, from your skin to your brain, and is inherited from your parents. This is the reality for individuals with Nevoid Basal Cell Carcinoma Syndrome, also known as Gorlin Syndrome. It's a rare genetic disorder that significantly increases the risk of developing certain types of cancer, particularly basal cell carcinoma, the most common form of skin cancer. While the name might sound intimidating, understanding this syndrome is the first step towards effective management and a better quality of life.
Nevoid Basal Cell Carcinoma Syndrome (NBCCS) is a genetic condition that causes abnormalities in various parts of the body. It's an inherited disorder, meaning it's passed down through families. The primary characteristic of NBCCS is a heightened susceptibility to developing basal cell carcinomas (BCCs) from a young age, often appearing after puberty. However, the syndrome's impact extends beyond the skin, potentially affecting the nervous system, bones, and other organs.
The syndrome is caused by a mutation in the PTCH1 gene. This gene plays a vital role in regulating cell growth and division. When this gene is faulty, the body loses its ability to control cell proliferation, leading to an increased risk of tumor formation.
You might hear NBCCS referred to by other names, including:
The symptoms of NBCCS can vary greatly from person to person, even within the same family. However, several common signs are associated with the condition:
The hallmark symptom is the development of multiple basal cell carcinomas. These typically begin to appear after puberty and can occur on any part of the body, especially areas exposed to the sun. These skin cancers often look like small, pearly or flesh-colored bumps or a scar-like lesion.
Beyond skin cancer, individuals with NBCCS have an increased risk of developing other cancers, often at a younger age than the general population. These can include:
Many individuals with NBCCS exhibit certain distinctive physical traits. These can include:
In more severe cases, NBCCS can affect the nervous system, potentially leading to:
NBCCS is an inherited genetic disorder. It follows an autosomal dominant inheritance pattern. This means that if one parent carries the altered gene, each child has a 50% chance of inheriting the gene and developing the syndrome. The specific gene involved is PTCH1, located on chromosome 9. This gene is a tumor suppressor gene, meaning it normally helps prevent cancer. A mutation in this gene disrupts its function, leading to uncontrolled cell growth.
While genetics is the primary cause, it's important to remember that not everyone with a family history will develop the syndrome, and in some rare instances, the gene mutation can occur spontaneously (de novo) without a family history.
Diagnosing NBCCS involves a combination of clinical evaluation and genetic testing. Your doctor will likely:
The doctor will inquire about your personal health history, including any previous diagnoses of cancer, and importantly, any family history of NBCCS or related conditions. A thorough physical examination will be conducted to look for the characteristic signs of the syndrome, such as multiple skin lesions, skeletal abnormalities, jaw tumors, and palmar/plantar pitting.
To further assess the extent of the condition, your doctor might order:
Genetic testing can confirm the presence of a mutation in the PTCH1 gene, providing a definitive diagnosis for NBCCS.
There is no cure for NBCCS itself, as it is a genetic condition. However, treatment focuses on managing the symptoms and preventing complications. The approach is highly individualized and depends on the specific manifestations in each person.
Regular skin surveillance by a dermatologist is paramount. Early detection and removal of basal cell carcinomas are key to preventing them from becoming advanced or spreading. Treatment options for BCCs include:
If other cancers, such as medulloblastoma, are diagnosed, treatment will involve a multidisciplinary team, often including oncologists and neurosurgeons. Jaw tumors (KCOTs) typically require surgical removal.
Skeletal problems like scoliosis may require bracing or surgery. Neurological issues, such as intellectual disability or hydrocephalus, are managed with supportive therapies, educational support, and sometimes surgical interventions like shunts for hydrocephalus.
While you cannot prevent the genetic inheritance of NBCCS, proactive management can significantly impact the long-term outlook. Consistent medical follow-ups and adherence to recommended screenings are vital.
Sun Protection: Given the high risk of skin cancer, diligent sun protection is essential. This includes wearing sunscreen with a high SPF, protective clothing, hats, and sunglasses, and avoiding peak sun hours.
Regular Check-ups: Annual or semi-annual visits to a dermatologist for full-body skin exams are non-negotiable. Early detection dramatically improves treatment outcomes for basal cell carcinomas.
The long-term outlook for individuals with NBCCS depends heavily on the severity of their symptoms and how well complications are managed. With vigilant monitoring and prompt treatment of skin cancers and other associated conditions, many individuals can lead full and productive lives. However, advanced or aggressive cancers can pose a more serious prognosis.
If you have a known family history of NBCCS or Gorlin Syndrome, it is crucial to discuss genetic counseling and regular screening with your doctor. Furthermore, if you notice any new or changing skin lesions, persistent jaw pain or swelling, or any other unusual symptoms that align with those described above, seek medical attention promptly.
Gorlin Syndrome is most often inherited, but in about 5-10% of cases, the gene mutation can occur spontaneously (de novo) without a family history.
There is no cure for the genetic condition itself. However, the symptoms and associated cancers can be effectively managed and treated.
With proper medical management and early detection of cancers, individuals with Gorlin Syndrome can have a normal or near-normal life expectancy. The prognosis depends on the development and management of associated cancers and other complications.
Basal cell carcinoma is the most common type of skin cancer and is typically slow-growing. It rarely spreads to other parts of the body. However, in NBCCS, these cancers can be more numerous and appear at a younger age.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026